Investigating immune interactions in Alzheimer's disease and testing a new immunotherapy
Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy
This study is looking at how inflammation might impact Alzheimer's disease by checking certain markers in your blood and spinal fluid, and it will also test a new low-dose treatment to see if it helps improve brain function and memory over 22 weeks for people with Alzheimer's.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11004684 on NIH RePORTER |
What this research studies
This research focuses on understanding how inflammation affects Alzheimer's disease by measuring specific inflammation biomarkers in blood and cerebrospinal fluid. It aims to compare these biomarkers with brain activity related to inflammation using advanced imaging techniques. Additionally, the study will evaluate the effects of a novel low-dose immunotherapy, interleukin-2, over a 22-week period on these biomarkers in individuals with Alzheimer's disease. Participants will also undergo cognitive assessments to determine any improvements in their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who are experiencing cognitive decline.
Not a fit: Patients with other forms of dementia or those not diagnosed with Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that improve cognitive function and slow the progression of Alzheimer's disease.
How similar studies have performed: Previous studies have shown promising results with immunotherapy approaches in Alzheimer's disease, indicating potential for success in this novel investigation.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Faridar, Alireza — Methodist Hospital Research Institute
- Study coordinator: Faridar, Alireza
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.